WeChat

简体中文
 

Achievements

  • Ningshao Xia & Tong Cheng: Broadly therapeutic antibody provides cross-serotype protection against enteroviruses via Fc effector functions and by mimicking SCARB2

    2024-10-18
  • Gang Liu: Sono-Triggered Biomimetically Nanoantibiotics Mediate Precise Sequential Therapy of MRSA-Induced Lung Infection

    2024-10-08
  • Hongmin Chen:Biodegradable copper-iodide clusters modulate mitochondrial function and suppress tumor growth under ultralow-dose X-ray irradiation

    2024-09-27
  • Ningshao Xia: Sequence-specific nanoparticle barcode strategy for multiplex human enterovirus typing

    2024-08-02
  • Jie Zhang: Gestational Exposure to PM2.5 and Specific Constituents, Meconium Metabolites, and Neonatal Neurobehavioral Development: A Cohort Study

    2024-06-12
  • Zhide Guo: Progressive Optimization of Lanthanide Nanoparticle Scintillators for Enhanced Triple-Activated Radioluminescence Imaging

    2024-05-16
  • Tianmu Chen: Temporal shifts in 24 notifiable infectious diseases in China before and during the COVID-19 pandemic

    2024-05-10
  • Quan Yuan:Evolving spike mutations in SARS-CoV-2 Omicron variants facilitate evasion from breakthrough infection-acquired antibodies

    2024-04-10
  • Ningshao Xia:Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

    2023-12-28
  • Ningshao Xia:Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18–26 years in China: a randomised blinded clinical trial

    2023-11-30